The Global Coated Endotracheal Tube Market size is expected to reach $238.2 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 9,493.1 thousand units experiencing a growth of 8.9% (2019-2022).
Respiratory conditions, including those requiring intubation, are prevalent in the Asia Pacific region. There is a growing awareness among healthcare professionals in the APAC region regarding the latest advancements in medical technologies. Consequently, the Asia Pacific region would acquire nearly 30% of the total market share by 2030. The growth of medical tourism increases the demand for advanced medical facilities and technologies in the region. These tubes, known for their benefits in respiratory care, contribute to the attractiveness of healthcare facilities in the Asia Pacific region. Some of the factors impacting the market are the growing prevalence of respiratory diseases, the increasing number of senior citizens and the high initial cost of these tubes.
The rising incidence of respiratory diseases globally drives the demand for advanced respiratory care solutions. These tubes, with their features aimed at minimizing complications, are increasingly used to manage respiratory diseases, contributing to market growth. Ventilator-associated pneumonia (VAP) is a common complication in ventilated patients with respiratory diseases. These tubes with anti-microbial properties play a crucial role in preventing VAP. By reducing the risk of respiratory infections, these tubes contribute to better outcomes for patients with respiratory diseases. The market is expanding significantly due to the growing prevalence of respiratory diseases. Additionally, as per the WHO, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050. Elderly patients often have unique healthcare needs, including a focus on comfort and well-being. These tubes, with features such as smoother surfaces and reduced friction, enhance patient comfort during intubation and ventilation. As a result of the increasing number of senior citizens, the market is anticipated to increase significantly.
Moreover, the surge in COVID-19 cases led to an increased demand for mechanical ventilation and, consequently, endotracheal intubation in severe cases. The risk of healthcare-associated infections, including VAP, became a critical concern during the pandemic. The pandemic prompted a shift in healthcare priorities, with an increased focus on critical care, respiratory support, and infection control measures. Thus, the COVID-19 pandemic had a positive effect on the market.
However, these tubes often cost more upfront than traditional uncoated tubes. The cost factor can be a barrier to adoption, particularly in healthcare systems where budget constraints are a significant concern. Reimbursement policies may not always align with the higher cost of advanced medical technologies. Healthcare providers may face challenges in securing adequate reimbursement for these tubes. This discrepancy between cost and reimbursement can discourage adoption, particularly if it affects the financial viability of healthcare institutions. Thus, high initial cost of these tubes can slow down the growth of the market.
On the basis of application, the market is divided into anesthesia, emergency medicine, and others. The emergency medicine segment recorded a remarkable revenue share in the market in 2022. Emergency medicine involves many clinical scenarios, from trauma cases to respiratory distress. Emergency medicine often deals with trauma cases and critical interventions requiring rapid intubation. These tubes, focusing on reducing complications and providing a smooth intubation process, are valuable in managing trauma cases and critical emergencies, improving the efficiency of airway management.
Based on intubation, the market is classified into orotracheal and nasotracheal. The nasotracheal segment acquired a substantial revenue share in the market in 2022. Nasotracheal intubation involves the passage of the tube through the smaller nasal passages, and coated tubes can contribute to smoother insertion, minimizing trauma. The reduced friction can be particularly beneficial in nasotracheal intubation procedures, potentially leading to increased adoption. These tubes, with their anti-microbial properties, contribute to infection prevention measures during nasotracheal intubation.
By end user, the market is categorized into hospitals, clinics, and ambulatory surgical centres. The clinics segment covered a considerable revenue share in the market in 2022. Clinics increasingly incorporate innovative healthcare technologies into their practices, including advanced endotracheal tubes with smart features. Integrating smart technologies, such as sensors and monitoring capabilities, enhances patient monitoring and facilitates real-time data collection in clinic settings. This drive for innovation contributes to adopting these tubes with advanced functionalities.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 150 Million |
| Market size forecast in 2030 | USD 238.2 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 6.1% from 2023 to 2030 |
| Number of Pages | 336 |
| Number of Tables | 669 |
| Quantitative Data | Volume in Thousand Units, Revenue in USD Million, and CAGR from 2019 to 2030 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Intubation, End User, Application, Region |
| Country scope |
|
| Companies Included | Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Patient safety and care quality are paramount concerns within North America's healthcare system. North America boasts advanced healthcare infrastructure and a robust medical technology landscape. The region's well-developed healthcare facilities are more inclined to adopt innovative technologies, including these tubes. The region's higher incidence of respiratory challenges drives the demand for technologies that minimize complications.
Free Valuable Insights: Global Coated Endotracheal Tube Market size to reach USD 238.2 Million by 2030
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH
By Intubation (Volume, Thousand Units, USD Million, 2019-2030)
By End User (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
This Market size is expected to reach $238.2 million by 2030.
Growing prevalence of respiratory diseases are driving the Market in coming years, however, High initial cost of coated endotracheal tubes restraints the growth of the Market.
Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH
In the year 2022, the market attained a volume of 9,493.1 thousand units experiencing a growth of 8.9% (2019-2022).
The Hospitals segment led the Market by End User in 2022; thereby, achieving a market value of $135 Million by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $78.2 Million by 2030.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
